- Home
- ANEB vs DTIL Comparison
ANEB vs DTIL Comparison
Compare ANEB & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- DTIL
- Stock Information
- Founded
- ANEB 2020
- DTIL 2006
- Country
- ANEB United States
- DTIL United States
- Employees
- ANEB N/A
- DTIL N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- ANEB Health Care
- DTIL Health Care
- Exchange
- ANEB Nasdaq
- DTIL Nasdaq
- Market Cap
- ANEB 79.9M
- DTIL 65.5M
- IPO Year
- ANEB 2021
- DTIL 2019
- Fundamental
- Price
- ANEB $1.93
- DTIL $8.82
- Analyst Decision
- ANEB Buy
- DTIL Strong Buy
- Analyst Count
- ANEB 1
- DTIL 2
- Target Price
- ANEB $8.00
- DTIL $39.50
- AVG Volume (30 Days)
- ANEB 13.3K
- DTIL 65.3K
- Earning Date
- ANEB 11-12-2024
- DTIL 11-05-2024
- Dividend Yield
- ANEB N/A
- DTIL N/A
- EPS Growth
- ANEB N/A
- DTIL N/A
- EPS
- ANEB N/A
- DTIL 3.39
- Revenue
- ANEB N/A
- DTIL $87,640,000.00
- Revenue This Year
- ANEB N/A
- DTIL $68.37
- Revenue Next Year
- ANEB N/A
- DTIL N/A
- P/E Ratio
- ANEB N/A
- DTIL $2.64
- Revenue Growth
- ANEB N/A
- DTIL 88.35
- 52 Week Low
- ANEB $1.72
- DTIL $8.25
- 52 Week High
- ANEB $3.30
- DTIL $19.43
- Technical
- Relative Strength Index (RSI)
- ANEB 49.10
- DTIL 38.50
- Support Level
- ANEB $1.83
- DTIL $8.75
- Resistance Level
- ANEB $1.96
- DTIL $9.18
- Average True Range (ATR)
- ANEB 0.08
- DTIL 0.42
- MACD
- ANEB 0.00
- DTIL -0.01
- Stochastic Oscillator
- ANEB 49.09
- DTIL 13.88
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.